Wearable Artificial Organ Growth Opportunities

Wearable Artificial Organ Growth Opportunities

Technological Innovations Enabling Remote Monitoring and Home Care for Organ Dysfunction

RELEASE DATE
27-Jul-2021
REGION
Global
Research Code: DA04-01-00-00-00
SKU: HC03435-GL-TR_25616
$4,950.00
In stock
SKU
HC03435-GL-TR_25616
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Healthcare providers typically manage kidney failure, diabetes, and respiratory failure with large, bulky medical equipment in a hospital setting. Conventional interventions typically reduce patient mobility; the treatment burden, mental anxiety, potential for non-compliance, and other drawbacks for specific therapies can result in poor health outcomes.

Wearable artificial organs are medical devices for the management of organ dysfunction. They perform the function of an organ while allowing patients to be mobile and independent inside or outside of their homes, or even in a hospital setting. This growth opportunity-technology (GO-TE) explores the emerging wearable artificial organ industry, discussing wearable kidneys, wearable pancreases, and wearable lungs.

The GO-TE explores various emerging innovations in the research stage and those that have been commercialized, and considers the future direction of each wearable. Technology and market drivers and challenges are explored in detail. Notable funding and acquisition activities in the last 2 years also are investigated. Growth opportunities offered by advanced sorbent technologies, artificial intelligence and the Internet of Things, advanced vascular access technologies, faster-acting insulin analogues, and dual-hormone insulin pumps are discussed. Strategic
recommendations for key participants are also put forth.

This research service also offers insights on the IP landscape and key patents in the last 5 years.

Table of Contents

1.1 The Strategic Imperative 8™

1.2 The Strategic Imperative 8™

1.3 The Impact of the Top Three Strategic Imperatives on the Wearable Artificial Organs Industry

1.4 Growth Opportunities Fuel the Growth Pipeline Engine™

2.1 Research Scope: Key Questions the Research Will Answer

2.2 Research Methodology

2.3 Key Findings

3.1 Diabetes and Poor Lifestyle are Common Causes of Organ Failure

3.2 Dialysis and Kidney Transplantation Are the Conventional Interventions for Kidney Dysfunction

3.3 Wearable Artificial Kidney Is the Next-generation Kidney Dialysis Therapy

3.4 Wearable Dialysis Devices Use Sorbent Technologies to Regenerate Dialysate

3.5 Glucose Management and Pancreas Transplantation Are the Conventional Interventions for Type 1 Diabetes

3.6 Wearable Artificial Pancreas Is a Closed-loop Insulin Delivery Device

3.7 Current-generation Wearable Pancreas Devices Are Hybrid Closed-loop Insulin Systems

3.8 Oxygen Therapy, Tracheostomy, and Mechanical Ventilation Are the Conventional Interventions for Chronic Respiratory Failure

3.9 Wearable Oxygen Concentrators and Ventilation Devices Provide Respiratory Support For Mobile Patients

3.10 Current-generation Portable Extracorporeal Oxygenation And Carbon Dioxide Removal Devices Allow ICU Mobility

3.11 Technology Segmentation: Wearable Artificial Organs Are Segmented Based on the Function

4.1 Impact Mapping of Growth Drivers of the Wearable Artificial Organs Industry

4.2 Shortage of Donor Organs will Drive the Wearable Artificial Organs Industry

4.3 Technology Advancements in AI, IoT, Telemedicine, and Nanoscience will Drive the Industry

4.4 Impact Mapping of Growth Challenges of the Wearable Artificial Organs Industry

4.5 High Cost of the Wearable Artificial Organs is a Major Challenge for the Industry

4.6 Emerging Bioartificial Organ Technology will Challenge the Industry

4.7 Increasing Incidence of Organ Dysfunction and Shortage of Donor Organs Enables the Growth of the Industry

5.1.1 Unique Sorbent Technology for Wearable Dialysis Devices

5.1.2 Peritoneal Dialysis Device Based on Nanoporous Sorbents

5.2.1 Implant Enabling Intraperitoneal Delivery of Insulin

5.2.2 AI-based Automated Insulin Delivery for Personalized Treatment

5.3.1 Wearable, Lightweight, and Detachable Ventilator

5.3.2 Fully Integrated Respiratory Dialysis System For Extracorporeal Carbon-dioxide Removal

6.1 Analysis of Funding Activities Shows Huge Interest in the Artificial Pancreas

6.2 Analysis of Key Acquisition Activities in Wearable Artificial Organs Industry Show Important Technology Deals

6.3 Wearable Artificial Pancreas Is Progressing Toward Fully Closed-loop Systems and Dual-hormone Pumps

6.4 Wearable Artificial Kidney Segment Is Advancing Toward an Implantable Bioartificial Kidney

6.5 Wearable Extracorporeal Gas Exchange Devices Will Be the Future of Wearable Artificial Lungs

7.1 Growth Opportunity 1: Integration of AI and IoT to Enable Automated and Personalized Function

7.1 Growth Opportunity 1: Integration of AI and IoT to Enable Automated and Personalized Function (continued)

7.2 Growth Opportunity 2: Advanced Sorbent Technologies to Enable Miniaturization and Increased Dialysis Efficiency

7.2 Growth Opportunity 2: Advanced Sorbent Technologies to Enable Miniaturization and Increased Dialysis Efficiency (continued)

7.3 Growth Opportunity 3: Advanced Vascular Access Technologies to Enable Reduced Risk of Complications With Wearable Dialysis

7.3 Growth Opportunity 3: Advanced Vascular Access Technologies to Enable Reduced Risk of Complications With Wearable Dialysis (continued)

7.4 Growth Opportunity 4: Fast-acting Insulin Analogues and Dual-hormone Pumps to Enable Better Glucose Control With Wearable Pancreas

7.4 Growth Opportunity 4: Fast-acting Insulin Analogues and Dual-hormone Pumps to Enable Better Glucose Control With Wearable Pancreas (continued)

7.5 Conclusions and Strategic Recommendations

8.1 Increasing IP Activity Indicates Growing Interest and Progress in Wearable Artificial Organs

8.2 Key Patents

8.2 Key Patents (continued)

8.2 Key Patents (continued)

9.1 Key Industry Participants

10.1 Your Next Steps

10.2 Why Frost, Why Now?

Legal Disclaimer

Related Research
Healthcare providers typically manage kidney failure, diabetes, and respiratory failure with large, bulky medical equipment in a hospital setting. Conventional interventions typically reduce patient mobility; the treatment burden, mental anxiety, potential for non-compliance, and other drawbacks for specific therapies can result in poor health outcomes. Wearable artificial organs are medical devices for the management of organ dysfunction. They perform the function of an organ while allowing patients to be mobile and independent inside or outside of their homes, or even in a hospital setting. This growth opportunity-technology (GO-TE) explores the emerging wearable artificial organ industry, discussing wearable kidneys, wearable pancreases, and wearable lungs. The GO-TE explores various emerging innovations in the research stage and those that have been commercialized, and considers the future direction of each wearable. Technology and market drivers and challenges are explored in detail. Notable funding and acquisition activities in the last 2 years also are investigated. Growth opportunities offered by advanced sorbent technologies, artificial intelligence and the Internet of Things, advanced vascular access technologies, faster-acting insulin analogues, and dual-hormone insulin pumps are discussed. Strategic recommendations for key participants are also put forth. This research service also offers insights on the IP landscape and key patents in the last 5 years.--BEGIN PROMO--

Increasingly prevalent kidney failure, diabetes and respiratory failure are conventionally managed by interventions which often reduce the mobility and independence of the patient. The mental anxiety and probable non-compliance of the patient lead to poor overall outcome in the patient. Emerging wearable artificial organs are wearable format medical devices which perform the function of an organ while allowing the patient to be mobile and productive, and it can be used in cases of organ dysfunction. Wearable artificial organs allow patient mobility inside or outside their homes, or within a hospital. The continuous therapy with wearable organs enables enhanced clinical outcome in the patient, and the increased independence enables increased productivity of the patient. The devices enable home care and elder care. The wearable artificial organs is also capable of facilitating remote or virtual therapy and monitoring of patients, which is of prime interest during the COVID-19 pandemic. This research service (RS) explores the wearable artificial organs industry with scope limited to wearable kidney, wearable pancreas and wearable lungs. The RS lists the various conventional interventions employed for kidney failure, diabetes and respiratory failure and its challenges. Wearable artificial organs (kidney, pancreas and lungs) are defined and their benefits are explored. Various wearable organs (kidney, pancreas and lungs) under development and commercialized are investigated. The report also covers some notable innovations in different segments of the industry. The technology and market drivers and challenges of the wearable artificial organs industry are explored in detail. Notable funding and acquisition activities in the last two years are also investigated. The growth opportunities offered by the advanced sorbent technologies, AI and IOT, advanced vascular access technologies, faster-acting insulin analogues and dual-hormone insulin pumps are discussed. Strategic recommendations for key participants are also put forth. In addition to the above, this research service also offers insights on the IP landscape and the key patents in the last five years.

More Information
No Index No
Podcast No
Author Sneha Maria Mariawilliam
Industries Healthcare
WIP Number DA04-01-00-00-00
Is Prebook No